Tarsus Pharmaceuticals (TARS) Earnings Date & Reports

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

TARS is expected to report earnings to rise 34.69% to -21 cents per share on August 06

Tarsus Pharmaceuticals TARS Stock Earnings Reports

Q2'26

Est.

$-0.22

Q1'26

Beat

by $0.14

Q4'25

Missed

by $0.12

Q3'25

Beat

by $0.05

Q2'25

Missed

by $0.10

The last earnings report on May 06 showed earnings per share of -15 cents, beating the estimate of -30 cents. With 152.43K shares outstanding, the current market capitalization sits at 2.74B.

View a ticker or compare two or three

Compare

TARS

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for TARS